1. Startpage
  2. Johannes Gutenberg-Universität Mainz
  3. DFG-491381577-H
Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-9945
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGerber, Tiemo S.-
dc.contributor.authorRidder, Dirk A.-
dc.contributor.authorGoeppert, Benjamin-
dc.contributor.authorBrobeil, Alexander-
dc.contributor.authorStenzel, Philipp-
dc.contributor.authorZimmer, Stefanie-
dc.contributor.authorJäkel, Jörg-
dc.contributor.authorMetzig, Marie Oliver-
dc.contributor.authorSchwab, Roxana-
dc.contributor.authorMartin, Steve Z.-
dc.contributor.authorKiss, András-
dc.contributor.authorBergmann, Frank-
dc.contributor.authorSchirmacher, Peter-
dc.contributor.authorGalle, Peter R.-
dc.contributor.authorLang, Hauke-
dc.contributor.authorRoth, Wilfried-
dc.contributor.authorStraub, Beate K.-
dc.date.accessioned2024-01-19T08:22:43Z-
dc.date.available2024-01-19T08:22:43Z-
dc.date.issued2024-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/9963-
dc.description.abstractDistinguishing primary liver cancer (PLC), namely hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA), from liver metastases is of crucial clinical importance. Histopathology remains the gold standard, but differential diagnosis may be challenging. While absent in most epithelial, the expression of the adherens junction glycoprotein N-cadherin is commonly restricted to neural and mesenchymal cells, or carcinoma cells that undergo the phenomenon of epithelial-to-mesenchymal transition (EMT). However, we recently established N- and E-cadherin expression as hallmarks of normal hepatocytes and cholangiocytes, which are also preserved in HCC and iCCA. Therefore, we hypothesized that E- and/or N-cadherin may distinguish between carcinoma derived from the liver vs carcinoma of other origins. We comprehensively evaluated E- and N-cadherin in 3359 different tumors in a multicenter study using immunohistochemistry and compared our results with previously published 882 cases of PLC, including 570 HCC and 312 iCCA. Most carcinomas showed strong positivity for E-cadherin. Strong N-cadherin positivity was present in HCC and iCCA. However, except for clear cell renal cell carcinoma (23.6% of cases) and thyroid cancer (29.2%), N-cadherin was only in some instances faintly expressed in adenocarcinomas of the gastrointestinal tract (0%–0.5%), lung (7.1%), pancreas (3.9%), gynecological organs (0%–7.4%), breast (2.2%) as well as in urothelial (9.4%) and squamous cell carcinoma (0%–5.6%). As expected, N-cadherin was detected in neuroendocrine tumors (25%–75%), malignant melanoma (46.2%) and malignant mesothelioma (41%). In conclusion, N-cadherin is a useful marker for the distinction of PLC vs liver metastases of extrahepatic carcinomas (P < .01).en_GB
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleN-cadherin: a diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomasen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-9945-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleInternational journal of cancerde
jgu.journal.volumeVersion of Record (VoR)de
jgu.publisher.year2024-
jgu.publisher.nameWiley-Liss,de
jgu.publisher.placeBognor Regisde
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1002/ijc.34836de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-491381577-H

Files in This Item:
  File Description SizeFormat
Thumbnail
ncadherin__a_diagnostic_marke-20240119091111297.pdf137.51 MBAdobe PDFView/Open
Show simple item record